Replies to post #127407 on Anavex Life Sciences Corp (AVXL)

[polarbear77]

And when Dr Perry says:

“I have never seen mild-to-moderate Alzheimer’s patients maintain near baseline cognitive and activities of daily living function and positive correlation with all other measures over a 41-week trial period in any prior study with an approved or experimental drug.”

Is he referring to just MMSE scores? He’s referring other cognitive tests as well isn’t he?

Do you disagree with the nation’s leading Alzheimer’s researcher? That’s fine if you do.

Again, I’m just listening to the experts and various CNS disease indications’ presentations and reading the slides & abstracts that are put in front of me.

By all means, anyone that is risk adverse should wait for FDA approval, if it comes. I am not a scientist.

Good luck

[mrplmer]

What does myself stand for?tia

[PeterKarol]

F1,
You are right. The average MMSE scores decline just like other studied placebo cohorts. Anybody looking at the data will shrug his shoulders and say "failed study".
The P300 and others do not confirm the diagnosis. As a matter of fact they deny it and point to success. They are in agreement with murine model pattern.